From: Improving the identification of priority populations to increase hepatitis B testing rates, 2012
 | n | % |
---|---|---|
Description of active patients | Â | Â |
 Total number of active patients | 33,297 |  |
Description of source population | 2,674 | 8.0Â % |
Method of population identification | Â | Â |
 Patients with Asian ethnicity | 2,654 | 99.3 % |
 Indigenous people | 18 | 0.7 % |
 People who inject drugs or with a history of injecting drugs | 2 | 0.1 % |
HBV infection and immunity status of source population | Â | Â |
 Patients with unknown HBV status | 2,274 | 85.1 % |
 Patients with known HBV status | 399 | 14.9 % |
  Chronic HBV detected (% among patients with known HBV status, n = 399) | 42 | (10.5 %) |
  Chronic HBV not detected (% among patients with known HBV status, n = 399) | 357 | (89.5 %) |
   Susceptible to HBV (% among patients with no evidence of chronic HBV, n = 357) | 78 | (21.8 %) |
   Immune to HBV (% among patients with no evidence of chronic HBV, n = 357) | 222 | (62.2 %) |
   Unknown immunity status (% among patients with no evidence of chronic HBV, n = 357) | 57 | (16.0 %) |
Eligible patients in source population (Patients with unknown HBV status and Patients with known HBV status that were susceptible to HBV or with unknown immunity status) | 2,409 | 90.1Â % |